Gastric inhibitory polypeptide (GIP) is an incretin secreted from enteroendocrine K cells in response to meal ingestion. Recently free fatty acid receptor G protein-coupled receptor (GPR) 120 was identified as a lipid sensor involved in glucagon-like peptide-1 secretion. However, Gpr 120 gene expression and its role in K cells remain unclear, partly due to difficulties in separation of K cells from other intestinal epithelial cells. In this study, we purified K cells using GIP-green fluorescent protein (GFP) knock-in mice, in which K cells can be visualized by GFP fluorescence. GFP-positive cells (K cells) were observed in the small intestine but not in the stomach and colon. K cell number and GIP content in K cells were significantly higher in the upper small intestine than those in the lower small intestine. We also examined the expression levels of several free fatty acid receptors in K cells. Among free fatty acid receptors, GPR120 was highly expressed in the K cells of the upper small intestine compared with the lower small intestine. To clarify the role of GPR120 on K cells in vivo, we used GPR120-deficient mice (GPR120 Ϫ/Ϫ ). GPR120 Ϫ/Ϫ exhibited significantly lower GIP secretion (75% reduction, P Ͻ .01) after lard oil ingestion compared with that in wild-type mice. Consistently, pharmacological inhibition of GPR120 with grifolic acid methyl ether in wild-type mice significantly attenuated lard oil-induced GIP secretion. In conclusion, GPR120 is expressed abundantly in K cells of the upper small intestine and plays a critical role in lipid-induced GIP secretion. (Endocrinology 156: 837-846, 2015) 
G astric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are incretins released from the gastrointestinal (GI) tract into circulation in response to meal ingestion (1, 2) . GIP is secreted from enteroendocrine K cells located in the upper small intestine; GLP-1 is secreted from enteroendocrine L cells located in the lower small intestine and colon. GIP and GLP-1 bind to the GIP re-ceptor (GIPR) and GLP-1 receptor on the surface of pancreatic ␤-cells, respectively (3), and potentiate insulin secretion glucose-dependently. GIPR and GLP-1 receptor are expressed in different tissues and both GIP and GLP-1 have many distinct physiological functions in vivo (4) .
GIPR-deficient mice exhibit insufficient compensatory insulin secretion during high-fat diet (HFD) feeding (5) , suggesting that GIP plays an important role in maintaining blood glucose levels by inducing hypersecretion of insulin in HFD-induced obesity. In addition, the sensitivity of GIPR to GIP in ␤-cells is increased in HFD-induced obese mice (6) . GIPR is also expressed in adipose tissue (7) , in which it increases glucose and triglyceride uptake (8, 9) . Thus, GIP has both direct and indirect effects on the accumulation of energy into adipose tissue (10) . Many studies report that GIP secretion is increased in obesity (10 -13) . Recently we established GIP-green fluorescent protein (GFP) knock-in (GIP-GFP) mice that enable us to visualize K cells by detecting GFP fluorescence and found that GIP mRNA expression in K cells and GIP content in the upper small intestine were significantly increased in HFD-fed mice compared with control-fat diet-fed lean mice, without a change in K cell number (14) . This result indicates that long-term HFD feeding induces GIP hypersecretion from K cells via an increase in Gip gene expression in K cells, thereby enhancing both direct and indirect effects of GIP on energy accumulation in adipose tissue. GIP is released from K cells into circulation in response to various nutrients (15) (16) (17) (18) . Measurement of total GIP and total GLP-1 levels in humans challenged with glucose or a meal showed that the postprandial plasma GIP levels were greatly augmented when a meal containing abundant fat, rather than simple glucose, was consumed (19, 20) . On the other hand, oral glucose induced GIP secretion is also potentiated in animals after long-term HFD feeding (14, 21) , suggesting the existence of both acute and chronic mechanisms stimulating GIP secretion in response to fat ingestion. Some G protein-coupled receptors (GPCRs) such as GPR40, GPR41, GPR43, GPR119, and GPR120 (22) (23) (24) (25) , were identified as sensing receptors for fatty acids or phospholipids. All of these receptors are involved in GLP-1 secretion, but their expression in K cells and their role in GIP secretion remain unclear. In this study, we found that not only K cell number but also GIP content and GIP mRNA expression in K cells are greater in the upper small intestine compared with those in the lower small intestine. We evaluated the expression of the GPCRs in the K cells of GIP-GFP mice and found that free fatty acid receptor (FFAR) GPR120 is highly expressed in K cells of the upper small intestine. We also clarified the role of GPR120 in GIP secretion using GPR120-deficient mice (GPR120 Ϫ/Ϫ ) and GPR120 partial agonist.
Research Design and Methods

Animals
We previously generated GIP-GFP mice in which enhanced green fluorescent protein (EGFP) gene was fused with exon 3 of the Gip gene to visualize K cells by enhanced green fluorescent protein in vivo (14) . We used heteromutant male mice to collect GFP-positive and GFP-negative cells (as K cells and non-K cells), respectively. GPR120 Ϫ/Ϫ (26) were generated as reported previously. All mice were on the C57BL/6 background. Nine-to 12-week-old male mice were used for all in vivo experiments. The mice were housed in an air-controlled (temperature 25°C) room with a dark-light cycle of 10 hours and 14 hours, respectively. Animal care and procedures were approved by Kyoto University Animal Care Committee.
Immunohistochemistry
The GI from the stomach to the appendix was taken from the mice, and the length of the small intestine (from the pylorus of the stomach to the ileocecal valve) was measured. The small intestine was divided into two portions at the middle position, and the oral and rectal portions were defined as the upper and lower small intestine, respectively. The stomach, the upper small intestine, the lower small intestine, and the colon samples of GIP-GFP heterozygous mice were fixed in Bouin's solution and washed with 70% ethanol before processing through paraffin. Rehydrated paraffin sections were incubated overnight at 4°C with primary mouse anti-GFP antibody (sc-9996, 1:100; Santa Cruz Biotechnology Inc) and rabbit anti-GIP antibody (kindly provided by Merck Millipore). The number of GFP-positive cells (K cells) was evaluated using fluorescent microscopy with a FSX100 (Olympus Corp). Fifty representative villi from each slide were randomly selected, and GFP-positive cells were quantified as the number of GFP-positive cells per length of villus.
Isolation and collection of K cells from mouse intestinal epithelium
The mouse stomach, the upper and the lower small intestine, and colon samples were removed and washed with PBS. The methods of isolation and collection of GFP-positive and GFPnegative cells from intestinal epithelial cells were previously described (14) . GFP-positive and GFP-negative cells in the intestinal epithelium were analyzed using BD FACS Aria flow cytometer (Becton Dickinson and C). The 7-amino-actinomycin D-positive cells were excluded as dead cells. Sorted cells were collected in medium-containing vials at a rate of 2000 cells/tube for RT-PCR (5000 cells/tube for GIP content). For the measurement of GIP content in K cells, the sorted samples were extracted with acid ethanol, and GIP levels and protein contents were measured by an ELISA assay (Merck Millipore).
RNA extraction and quantitative RT-PCR
Total RNA from the sorted cells was extracted with a Pico Pure RNA isolation kit (Applied Biosystems, Inc) and treated with deoxyribonuclease (QIAGEN Inc). cDNA was prepared by reverse transcriptase (Invitrogen) with an oligodeoxythymidine primer (Invitrogen). The mRNA levels were measured by quantitative RT-PCR using ABI PRISM 7000 Sequence Detection System (Applied Biosystems Inc). PCR analyses were carried out using oligonucleotide primers. SYBR Green PCR master mix (Applied Biosystems Inc) was prepared for the PCR run. Peptidylprolyl isomerase A was used as the internal control. All of the data were shown using cycle threshold (CT) methods [CT (internal control) Ϫ CT (target gene)]. The primers of target molecules were designed as those in Supplemental Table 1 .
Oral glucose tolerance test (OGTT) and oral lard oil tolerance test (OLTT)
After a 16-hour fasting period, OGTTs (2 g/kg body weight for measurements of blood glucose, insulin, and total GIP) (6 g/kg body weight for measurement of total GLP-1) and OLTTs (10 mL/kg body weight) were performed. Blood samples were taken at the indicated times (0, 30, 60, and 120 min after glucose or lard oil loading), and blood glucose levels, plasma insulin levels, and plasma total GIP and total GLP-1 levels were measured. Blood glucose levels were determined by the glucose oxidase method (Sanwa Kagaku Kenkyusho Co Ltd). Plasma insulin levels were determined using an ELISA kit (Shibayagi). Plasma total GIP and total GLP-1 levels were determined using a total GIP ELISA assay kit (Merck Millipore) and total GLP-1 assay kit (Meso Scale Discovery), respectively. Grifolic acid methyl ether is a GPR120 partial agonist that can inhibit the long-chain fatty acid-induced ERK and Ca 2ϩ response in GPR120-expressing cells (27) . Grifolic acid methyl ether purified at Tokushima Bunri University (Tokushima, Japan) was prepared as described previously (27, 28) . After a 16-hour fast, the grifolic acid methyl ether (80 mg/kg body weight) was administered orally. Thirty minutes later, an OLTT was performed as described above. Lard oil was purchased from Bell Shokuhin Co. The lard oil contained 1% myristic acid, 27% palmitic acid, 3% palmitoleic acid, 14% stearic acid, 46% olenic acid, and 9% ␣-linolenic acid.
Intestinal perfusion experiment
To selectively administer lard oil into the upper small intestine, a tube was inserted at the pylorus of the stomach, and lard oil was injected at the speed of 1 mL/min through the tube for 10 minutes. Injected lard oil was collected at the middle position of the small intestine before reaching the lower portion. Likewise, a tube was inserted at the middle position of the small intestine and ileocecal position and lard oil was injected. After administration of lard oil for 10 minutes, blood samples was collected from the portal vein and total GIP level was measured by ELISA (29) .
Analysis
The results are given as mean Ϯ SEM (n ϭ number of mice). Statistical significance was determined using paired and unpaired Student's t test and ANOVA with Games-Howell. P Ͻ .05 was considered significant.
Results
K cell number in GI tract of GIP-GFP mice
Green fluorescent cells were observed in the upper and the lower small intestine under fluorescent microscopy ( Figure 1A) . The cells were not detected in stomach or colon (data not shown). Immunohistochemistry also revealed that GIP-positive cells, matching GFP-positive cells, are detected in the upper and the lower small intestine ( Figure 1B) but not in the stomach or colon (data not shown). To evaluate the number of GFP-positive cells, flow cytometry analysis was performed ( Figure 1C ). This showed that the number of GFP-positive cells in the upper and the lower small intestine was 0.052% Ϯ 0.004% and 0.028% Ϯ 0.002% of all intestinal epithelial cells, respectively. An immunohistochemical analysis also showed that the number of GFP-positive cells per length of villus in the upper small intestine was significantly greater than that in the lower small intestine ( Figure 1D ), although the villus was significantly longer in the upper small intestine than that in the lower small intestine ( Figure 1E ).
GIP expression and content in the K cells of the upper and lower small intestine
To collect GFP-positive and GFP-negative cells as K cells and non-K cells, flow cytometry was used. We collected the GFP-positive cells and GFP-negative cells from the upper or lower small intestine using the same threshold of intensity level of green fluorescence ( Supplemental Figure 1) and found that the areas of the green fluorescence were moderately, but significantly, higher in GFP-positive cells of the upper small intestine than those of the lower small intestine ( Figure 2A ). The levels of GIP content in a GFP-positive cell were 2-fold higher in the upper small intestine than those of the lower intestine ( Figure 2B ). The GIP content was not detectable in GFP-negative cells of both the upper and the lower small intestine.
RT-PCR showed that expression levels of GFP mRNA and GIP mRNA were significantly higher (4-fold) in GFPpositive cells of the upper small intestine compared with those of the lower small intestine ( Figure 2 , C and D), whereas their expression could not be detected at all in GFP-negative cells. The expression levels of GFP mRNA and GIP mRNA in GFP-positive cells were not changed after the removal of dead cell using 7-amino-actinomycin D (Supplemental Figure 2 ). We also evaluated GLP-1 mRNA expression in GFP-positive and GFP-negative cells. GLP-1 mRNA levels tended to be higher in GFPnegative cells relative to those in GFP-positive cells but without a statistically significant difference ( Figure 2E ).
Expressions of FFARs mRNA in K cells
To evaluate the expression levels of different FFARs, RT-PCRs were performed ( Figure 3 ). GPR40 was highly expressed in GFP-positive cells of the lower small intestine, whereas GPR120 was highly expressed in GFP-positive cells of the upper small intestine ( Figure 3, A and B) . Although GPR119 showed a tendency toward abundance in GFP-positive cells of the lower small intestine, the difference was not significant ( Figure 3C ). GPR41 was mainly expressed in GFP-positive cells of the lower intestine; however, there was no significant difference in the expression between GFP-positive and GFP-negative cells in the lower small intestine ( Figure 3D ). GPR43 was highly expressed in GFP-positive cells of the lower small intestine ( Figure 3E ).
GIP secretion in GPR120-deficient mice
To evaluate the effect of GPR120 on GIP secretion, we performed OGTT and OLTT and compared total GIP secretion in wild-type (WT) mice and GPR120 Ϫ/Ϫ . In GPR120 Ϫ/Ϫ , total GIP levels during the OGTT were similar to those in WT mice ( Figure 4A ). Blood glucose levels, as well as insulin levels during OGTT, did not differ between WT and GPR120 Ϫ/Ϫ , except for a single change in blood glucose levels at 120 minutes (Figure 4 , C and E). In contrast, total GIP levels in response to lard oil were significantly lower in GPR120 Ϫ/Ϫ ( Figure 4B ). The reduction of GIP secretion [area under the curve (AUC) of total GIP levels] was 75%. Consistent with this, blood glucose levels at 60 and 120 minutes, as well as AUC-glucose during the OLTT, were significantly higher in GPR120 Ϫ/Ϫ ( Figure  4D ). Insulin levels at 30 minutes after lard oil administration were higher in WT than those in GPR120 Ϫ/Ϫ ( 4F). However, there was no significant difference in insulin levels and insulin secretion (AUC-insulin). In the OGTT and OLTT, GLP-1 secretion was not different between WT and GPR120 Ϫ/Ϫ (Figure 4, G and H) .
To compare lard oil-induced GIP secretion from the upper small intestine and that from the lower small intestine in vivo, we performed an intestinal perfusion experiment using WT and GPR120 Ϫ/Ϫ ( Figure 4I ). Lard oilinduced GIP secretion was significantly higher in the upper small intestine compared with that in the lower small intestine in WT mice. Lard oil-induced GIP secretion from both the upper and the lower portions of the small intestine was significantly decreased in GPR120 Ϫ/Ϫ compared with that in WT mice.
Effect of pharmacological GPR120 inhibition on GIP secretion from K cells
To clarify the effect of pharmacological GPR120 inhibition on GIP secretion after glucose and fat ingestion, we performed an OGTT and OLTT in WT mice treated with or without grifolic acid methyl ether, as shown in Figure 5I . Oral pretreatment with grifolic acid methyl ether attenuated lard oil-induced GIP secretion ( Figure 5B ) by approximately 80% but not glucose-induced GIP secretion ( Figure 5A ). In both OGTT and OLTT experiments, blood glucose, insulin, and GLP-1 levels were not significantly different between the mice treated with grifolic acid methyl ether and control, except for a single change in blood glucose levels at 120 minutes during OGTT ( Figure 5 , C-H).
Discussion
K cells are distributed mainly in the upper small intestine as detected by immunohistochemical analysis using anti-GIP antibody (30, 31) , and their density decreases farther down the lower small intestine (31) . In this study, we examined the intestinal distribution of K cells using GIP-GFP mice, in which K cells can be visualized by GFP. Our results using anti-GFP antibody in GIP-GFP mice confirmed that the K cell (GFP-positive cell) number was significantly greater in the upper small intestine than that in the lower small intestine ( Figure 1D ). Previous reports indicated that K cells can be found outside the small intestine, such as in the stomach and the colon (32, 33) , but no K cells were found in these locations in our experiment. In this study, we show for the first time the ratio of K cells in intestinal epithelium in vivo using flow cytometer. Flow cytometry analysis revealed that the number of K cells was 2-fold higher in the upper small intestine than that in the lower small intestine (0.052% Ϯ 0.004%, 0.028% Ϯ 0.002%) ( Figures 1C and 6 ). Intestinal epithelial cells were isolated with trypsin and cell number was determined by flow cytometry. After the isolation, we confirmed by microscopy that the lamina muscularis mucosae and the subserosal layers were intact, suggesting that intestinal epithelium cells were selectively collected. Thus, we measured the number of K cells accurately using GIP-GFP mice.
There are difficulties in the evaluation of GIP expression and GIP content in K cells, primarily due to problems in separating K cells from other intestinal epithelial cells in vivo. Using GIP-GFP mice, we were able to measure GIP mRNA expression and GIP content in K cells of the upper and the lower small intestine, and we determined that GIP mRNA expression and GIP content were significantly higher in the K cells of the upper small intestine than those in the lower small intestine (Figure 2, B and  D) . In addition, intestinal perfusion showed that lard oil-induced GIP secretion was significantly greater in upper small intestine compared with that in the lower small intestine in WT mice ( Figure 4I) . These results suggest that K cells in the upper small intestine contribute more to nutrient-induced GIP secretion than K cells of the lower small intestine. In previous human studies, GIP secretion in response to glucose occurs immediately after nutrient ingestion (34, 35) , and it depends on the dose of the oral glucose administration (20, 36) . In addition, the GIP secretory response to fat-containing mixed meal is stronger than that to oral glucose load, whereas the responses of GLP-1 are similar between both tests, indicating that fat ingestion notably increases GIP secretion (19, 20) . Our results showing that the GIP content in K cells as well as the K cell number are high in the upper small intestine ( Figure 6 ) are consistent for GIP secretion from K cells in response to the amount (quality) and composition (quantity) of meal. There are several FFARs involved in incretin secretion. Receptors for long-chain fatty acids (GPR40 and GPR120) (22, 23), short-chain fatty acids (GPR41 and GPR43) (25) , and oleoylethanolamide (GPR119) (24) are known to be involved in GLP-1 secretion. However, the role of FFARs, except for GPR40 and GPR119, in GIP secretion from K cells remains unclear (22, 24) . In this study, we found that GPR120 is abundantly expressed in the K cells of the upper small intestine ( Figure 6 ). To examine the role of GPR120 in GIP secretion, we measured GIP levels after oral lard oil administration in WT and GPR120 Ϫ/Ϫ . Lard oil increased GIP secretion in WT mice because it consists of several fatty acids that activate GPR120. GIP secretion induced by lard oil was not as great in GPR120 Ϫ/Ϫ mice compared with WT mice (Figure 4, B and I) . On the other hand, glucose-induced GIP secretion was similar between WT and GPR120 Ϫ/Ϫ ( Figure  4A ). Furthermore, we used grifolic acid methyl ether, which competitively inhibits long-chain fatty acid-in- duced activation of GPR120 signaling (27) . Treatment of mice with grifolic acid methyl ether resulted in decreased lard oil-induced GIP secretion ( Figure 5B ) but not glucoseinduced GIP secretion ( Figure 5A ).
These results suggest that fatty acids derived from lard oil stimulate GIP secretion through GPR120 signaling. We did not detect significant differences in serum insulin levels between WT and GPR120 Ϫ/Ϫ during the OLTT ( Figure 4F ), even though GIP is an incretin. This could be the result of the small increase in plasma glucose levels during the OLTT because GIP induces glucose-dependent insulin secretion. Furthermore, GLP-1 levels after lard oil administration were not different between WT and GPR120 Ϫ/Ϫ ( Figure 4H ), and grifolic acid methyl ether did not decrease GLP-1 levels during OLTT ( Figure 5H ). Previous in vitro studies showed that ␣-linolenic acid-induced GLP-1 secretion was decreased in GPR120-knockdown STC-1 cells (a murine intestinal cell line) and was not induced in NCI-H716 cells (a human intestinal cell line) transfected with Gpr120 mutation (R270H) compared with controls (23, 26) . However, a recent paper showed that corn oil-induced GLP-1 levels were not decreased in GPR120 Ϫ/Ϫ compared with those in WT mice (37) . In the present study, we used lard oil to evaluate GIP secretion because we previously showed that chronic lard oil-containing HFD feeding induces GIP expression in K cells and GIP hypersecretion (14) . Contents of fatty acids in lard oil might affect GIP secretion more potently than GLP-1 secretion through GPR120 in vivo. We also found that GPR40 mRNAs are highly expressed in K cells of the lower small intestine ( Figure 6 ). Previous in vitro studies using GPR40-and GPR120-expressing cells show that both receptor signalings are induced by very similar medium-chain and long-chain fatty acids (23, 38) . However, GIP secretion from K cells of the upper and the lower small intestine in response to various fatty acids has not yet been examined in detail. In addition, the receptor expression in K cells has not yet been compared with those in L cells in vivo. To clarify the role of GPR40 and GPR120 in fat-induced GIP secretion, further studies are needed using GPR40-and GPR120deficient mice.
Some studies have reported that more than two GI hormones can be coexpressed in an enteroendocrine cell (39 - Figure 6 . Characterization of K cells in the upper and the lower small intestine. K cell number and GIP content in K cells were significantly higher in the upper small intestine than that in the lower small intestine. GPR120 was abundantly expressed in K cells of the upper small intestine. GPR40 and GPR43 were highly expressed in K cells of the lower small intestine. doi: 10.1210/en.2014-1653 endo.endojournals.org 41) and that GIP and GLP-1 are coexpressed in K cells (K/L cells) (30, 42) . Our results show that GLP-1 expression tends to be higher in non-K cells (GFP-negative cells) compared with that in K cells ( Figure 2E ). Taken together, these results suggest that most isolated K cells are not K/L cells. A previous study reported that GPR40, GPR119, and GPR120 are highly expressed in K cells compared with non-K cells isolated from the upper small intestine of rat Gip promoter-yellow fluorescent protein (YFP) transgenic mice (42) . These results differ from our results in that we found GPR40 mRNA and GPR119 mRNA expressions to be very low in K cells and non-K cells of the upper small intestine ( Figure 3 , A and C). It should be considered that YFP protein is expressed under a long rat Gip promoter transgene (200 kbp) derived from a BAC clone in GIP-YFP transgenic mice (43) , whereas GFP protein is expressed under an endogenous native promoter in our GIP-GFP mice. GPR120, GPR40, and GPR119 mRNAs are expressed in L cells in the upper and the lower small intestine as well as the colon (44) . In the current study, it is unclear why expression levels of these GPCRs were very low in the GFP-negative cell population that might include L cells (Figure 3 , A-C). One possibility is that because L cells comprise a very small proportion of the GFP-negative cell population, the expression levels of these genes were undetectable. Several lines of evidence using GIPR-knockout mice and a GIP receptor antagonist suggest that inhibition of GIPR signaling is a promising approach to obesity (10, (45) (46) (47) . We also have reported that chronic reduction of GIP secretion ameliorates HFD-induced obesity and insulin resistance (21) , suggesting that suppression of GIP secretion could be a therapeutic strategy against obesity (48) . In this study, defective GPR120 signaling resulted in decreased GIP secretion (Figures 4 and 5) . In contrast, a previous study showed that HFD-fed GPR120 Ϫ/Ϫ gain more body weight and have higher insulin resistance compared with HFD-fed WT mice (26) . Taken together, these results suggest a more complex role of GPR120 in dietinduced obesity. In fact, GPR120 is also expressed in adipocytes and macrophages and plays a role in chronic inflammation and insulin resistance in obesity (49) . Therefore, the phenotype of whole-body GPR120 Ϫ/Ϫ cannot be explained simply by decreased GIP secretion from K cells. It is therefore necessary to establish a specific GPR120 antagonist that can inhibit only GPR120 signaling in the GI tract and to evaluate the effect of GIP secretion modified by GPR120 inhibition in HFD-induced obesity.
In conclusion, we show that K cells are distributed exclusively in the small intestine and are located mainly in the upper small intestine by evaluation of K cell num-ber and GIP content. We also show that GPR120 is mainly expressed in the K cells of the upper small intestine and plays a critical role in lipid-induced GIP secretion from K cells.
